Company news

Vitasora Health Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Reinstatement to Official Quotation

December 13, 2023

$6.5m raised for US expansion, $20m commitment secured

December 13, 2023

Voluntary Suspension

November 30, 2023

Response to ASX Query

November 2, 2023

Further USA Customer Base Growth - ShareCafe Presention

September 29, 2023

Early Redemption of Convertible Note - $1.3m Placement

September 18, 2023

Preliminary Final Report

August 31, 2023

Access secure new $900k annual revenues fr RPM/RTM contracts

August 28, 2023

Respiri completes acquisition of Access Managed Services

August 13, 2023

Completion of private placement

August 11, 2023

SPP strongly supported raising $3m

August 8, 2023

Access Telehealth acquisition presentation

June 6, 2023

RSH acquires US based Access RPM, capital raise and new NED

May 23, 2023

Half Yearly Report and Accounts

February 27, 2023

Successful close of Share Purchase Plan

February 13, 2023

RPM successfully reimbursed and claimed by physicians

February 5, 2023

Security Purchase Plan extension of closing date

January 24, 2023

Nth Carolina hospital commence wheezo RPM patient onboarding

January 8, 2023

Security Purchase Plan

December 27, 2022

Arkansas Heart Hospital commences patients on wheezo RPM

December 22, 2022

wheezo RPM program expands into New Mexico USA

December 15, 2022

First patients selected and enrolled into Minnesota Lung Ctr

December 13, 2022

First primary care practice secured and first patients

December 6, 2022

wheezo RPM program selected by leading USA heart center

November 27, 2022

Minnesota Lung Centre select wheezo and RMP for pilot prog.

November 17, 2022

Chairman and CEOs Presentation to Shareholders

November 14, 2022

Key milestone - First patients enrol into wheezo RPM program

November 6, 2022

Centre of Digital Innovation Excellence established

September 27, 2022

Placement of $1.6m to Support US Expansion

September 21, 2022

Investor USA market update and presentation

August 17, 2022

Monthly Activities/Appendix 4C Cash Flow Report

July 29, 2022

Wheezo successfully integrated in Michigan Children Hospital

July 28, 2022

Investor presentation

July 15, 2022

New GBP2m NIHR-Funded UK Paediatric Asthma Clinical Trial

July 11, 2022

Reinstatement to Quotation

May 2, 2022

Completion of Placement

May 2, 2022

RPM pilot program at Childrens Hospital of Michigan

March 14, 2022

Second RPM Agreement with Access TeleHealth

February 6, 2022

Respiri secures a second order from mTeleHealth

February 3, 2022

Respiri enters Distribution/Marketing Agreement in USA

December 22, 2021

Clarification Announcement

July 4, 2021

Webinar presentation - Investor Update

June 23, 2021

Pharmacy Network to Commence Sales of wheezo

June 22, 2021

Trading Update

June 14, 2021

Appendix 4C - quarterly

April 29, 2021

Respiri Partnership with TerryWhite Chemmart Group

April 27, 2021

Investor Presentation

March 22, 2021

Half Year Accounts

February 19, 2021

Company Update Post Commercial Launch

December 8, 2020

Manufacturing update

November 3, 2020

← Newer news releases · Older news releases →

Decks

The 5 newest of 15 decks. Every deck is listed under its year.